Chen MB - Search Results

1

PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling.

Liu N, Zhu XR, Wu CY, Liu YY, Chen MB, Gu JH. Liu N, et al. Among authors: chen mb. Cell Death Discov. 2024 Nov 22;10(1):478. doi: 10.1038/s41420-024-02240-8. Cell Death Discov. 2024. PMID: 39578429 Free PMC article. Review.

2

Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells.

Chen MB, Wu XY, Gu JH, Guo QT, Shen WX, Lu PH. Chen MB, et al. Cell Biochem Biophys. 2011 Jul;60(3):311-22. doi: 10.1007/s12013-011-9153-0. Cell Biochem Biophys. 2011. PMID: 21274754

3

Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.

Chen MB, Shen WX, Yang Y, Wu XY, Gu JH, Lu PH. Chen MB, et al. J Cell Physiol. 2011 Jul;226(7):1915-25. doi: 10.1002/jcp.22522. J Cell Physiol. 2011. PMID: 21506122

4

Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification.

Chen MB, Gu JH, Wu XY, Lu PH, Gu RM. Chen MB, et al. Breast Cancer Res Treat. 2011 Oct;129(3):1011-3. doi: 10.1007/s10549-011-1563-6. Epub 2011 May 11. Breast Cancer Res Treat. 2011. PMID: 21559823 No abstract available.

5

Genetic polymorphisms of UGT1A7 and cancer risk: evidence from 21 case-control studies.

Lu PH, Chen MB, Wu XY, Gu JH, Liu Y, Gu RM. Lu PH, et al. Among authors: chen mb. Cancer Invest. 2011 Dec;29(10):645-54. doi: 10.3109/07357907.2011.626477. Cancer Invest. 2011. PMID: 22085268

6

C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling.

Chen MB, Jiang Q, Liu YY, Zhang Y, He BS, Wei MX, Lu JW, Ji Y, Lu PH. Chen MB, et al. Carcinogenesis. 2015 Sep;36(9):1061-70. doi: 10.1093/carcin/bgv094. Epub 2015 Jun 25. Carcinogenesis. 2015. PMID: 26116623

7

Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.

Zeng P, Wang YH, Si M, Gu JH, Li P, Lu PH, Chen MB. Zeng P, et al. Among authors: chen mb. Oncotarget. 2017 Jan 17;8(3):5592-5602. doi: 10.18632/oncotarget.13532. Oncotarget. 2017. PMID: 27888619 Free PMC article.

8

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.

Lu PH, Chen MB, Liu YY, Wu MH, Li WT, Wei MX, Liu CY, Qin SK. Lu PH, et al. Among authors: chen mb. Oncotarget. 2017 Apr 4;8(14):22800-22810. doi: 10.18632/oncotarget.15205. Oncotarget. 2017. PMID: 28206952 Free PMC article.

9

Ulk1 over-expression in human gastric cancer is correlated with patients' T classification and cancer relapse.

Chen MB, Ji XZ, Liu YY, Zeng P, Xu XY, Ma R, Guo ZD, Lu JW, Feng JF. Chen MB, et al. Oncotarget. 2017 May 16;8(20):33704-33712. doi: 10.18632/oncotarget.16734. Oncotarget. 2017. PMID: 28410240 Free PMC article.

10

Identification of DNA-PKcs as a primary resistance factor of TIC10 in hepatocellular carcinoma cells.

Cheng L, Liu YY, Lu PH, Peng Y, Yuan Q, Gu XS, Jin Y, Chen MB, Bai XM. Cheng L, et al. Among authors: chen mb. Oncotarget. 2017 Apr 25;8(17):28385-28394. doi: 10.18632/oncotarget.16073. Oncotarget. 2017. PMID: 28415690 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters